Determine facility and waste scope

Identify whether the site is a healthcare facility, reverse distributor, or another generator. Inventory prescription and over-the-counter products, nicotine products, controlled substances, spill residues, devices, and non-pharmaceutical hazardous waste.

Separate credit pathways

Potentially creditable prescription pharmaceuticals move through reverse distribution under specific conditions. Non-creditable hazardous waste pharmaceuticals generally require management and shipment to a RCRA-designated facility under Subpart P.

Implement the sewer prohibition

The federal prohibition on sewering hazardous waste pharmaceuticals applies broadly within its scope. Train clinical, pharmacy, laboratory, environmental-services, and maintenance personnel on collection points and exceptions.

Worked example: hospital pharmacy cleanout

A hospital separates potentially creditable unopened prescriptions, non-creditable expired hazardous pharmaceuticals, DEA-controlled hazardous waste pharmaceuticals, and ordinary nonhazardous pharmaceutical waste. It documents each route and prevents incompatible or unauthorized commingling.

Manage containers, records, and vendors

Define accumulation areas, labeling, closure, incompatible waste controls, spill response, shipping records, reverse-distributor verification, and rejected shipment handling.

Put the requirement into daily work

Assign an accountable owner and translate the hazardous waste pharmaceuticals Subpart P decision into a field standard. Identify who performs each step, who reviews exceptions, what training and equipment are required, and where evidence is retained. Test the workflow with a real facility example before broad use.

Connect environmental, operations, maintenance, laboratory, purchasing, shipping, emergency-response, and contractor roles where their decisions affect the outcome. Use clear acceptance criteria so the same facts produce the same decision.

Records and reevaluation triggers

Keep the current regulatory basis, facility analysis, approvals, operating records, and exception history under a stable identifier. A reviewer should be able to reconstruct what was known, who decided, how the control was implemented, and how ongoing performance was verified.

Reevaluate after changes in material, process, equipment, quantity, storage, handling, vendor, destination, permit, law, incident, inspection finding, analytical result, or recurring failure. Document both the trigger and the resulting decision.

Common mistakes

• Sending non-creditable waste through reverse distribution.
• Assuming all pharmaceuticals are hazardous waste.
• Sewering a hazardous waste pharmaceutical.
• Ignoring nicotine listing changes and state adoption.
• Mixing DEA-controlled and non-controlled wastes without a pathway.